230
Views
37
CrossRef citations to date
0
Altmetric
Research Article

Effects of cypermethrin on monoamine transporters, xenobiotic metabolizing enzymes and lipid peroxidation in the rat nigrostriatal system

, , , , , , , & show all
Pages 1416-1424 | Received 05 Jul 2010, Published online: 06 Sep 2010

References

  • Burke RE. Parkinson's Disease. Koliatsos VE, Ratan RR. Cell death and diseases of the nervous system. Totowa, New Jersey: Humana; 1999. 459–475.
  • Jankovic J, Wooten M, Van der Linden C, Jansson B. Low body weight in Parkinson's disease. South Med J 1992;85: 351–354.
  • Singh MP, Patel S, Dikshit M, Gupta YK. Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease. Indian J Biochem Biophys 2006;43:69–81.
  • Srivastava G, Singh K, Tiwari MN, Singh MP. Proteomics in Parkinson's disease: current trends, translational snags and future possibilities. Expert Rev Proteomics 2010;7: 127–139.
  • Aschner M. Manganese in health and disease. Massaro EJ. From transport to neurotoxicity. Handbook of neurotoxicology. Totowa, New Jersey: Humana: 2000. 195–209.
  • Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 1998;50: 1346–1350.
  • Kumar A, Ahmed I, Shukla S, Singh BK, Patel DK, Pandey HP, Singh C. Effect of zinc and paraquat co-exposure on neurodegeneration: modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats. Free Radic Res 2010; DOI: 10.3109/10715762.2010.492832.
  • Patel S, Pandey A, Bajpayee M, Parmar D, Dhawan A. Cypermethrin-induced DNA damage in organs and tissues of the mouse: evidence from the comet assay. Mutat Res 2006;607: 176–183.
  • Singh C, Ahmad I, Kumar A. Pesticides and metals induced Parkinson's disease: involvement of free radicals and oxidative stress. Cell Mol Biol 2007;53:19–28.
  • Thiruchelvam M, Richfield EK, Goodman BM, Baggs RB, Cory-Slechta DA. Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 2002;23:621–633.
  • Saxena PN, Chauhan LK, Gupta SK. Cytogenetic effects of formulation of cypermethrin in root meristem cells of Allium sativum: spectroscopic basis of chromosome damage. Toxicology 2005;216:244–252.
  • Dayal M, Parmar D, Dhawan A, Ali M, Dwivedi UN, Seth PK. Effect of pretreatment of cytochrome P450 (P450) modifiers on neurobehavioral toxicity induced by deltamethrin. Food Chem Toxicol 2003;41:431–437.
  • Parkinson A. Biotransformation of xenobiotics. Klaassen CD. Casarett and Doull's toxicology - The basic sciences of poison. New York: McGraw Hill; 2001. 133–224.
  • Walker AP, Bacherald HS. Studies on DNA damage and repair in mammalian brain. J Neurochem 1988;51:1394–1399.
  • Crawford MJ, Croucher A, Hutson DH. Metabolism of cis- and trans-cypermethrin in rats. Balance and tissue retention study. J Agric Food Chem 1981;29:130–135.
  • Gowland B, Webster L, Fryer R, Davies I, Moffat C, Stagg R. Uptake and effects of the cypermethrin-containing sea lice treatment Excis in the marine mussel Mytilus edulis. Environ Pollut 2002;120:805–811.
  • Ramadan AA. Action of pyrethroids on K+ simulated calcium uptake by, and [3H] nimodipine binding to, rat brain synaptosomes. Pest Biochem Physiol 1988;32:114–122.
  • Rao GV, Rao KSJ. Inhibition of monoamine oxidase-A of rat brain by pyrethroids-an in vitro kinetic study. Mol Cell Biochem 1993;124:107–114.
  • Smith TJ, Soderlund DM. Potent actions of the pyrethroid insecticides cismethrim and cypermethrin on rat tetrodotoxin-resistant peripheral nerve (SNS/PN3) sodium channels expressed in Xenopus oocytes. Pest Biochem Physiol 2001; 70:52–61.
  • Barbeau A, Roy M, Cloutier T, Plasse L, Paris S. Environmental and genetic factors in the etiology of Parkinson's disease. Adv Neurol 1987;45:299–306.
  • Bocchetta A, Corsini GU. Parkinson's disease and pesticides. Lancet 1986;2:1163.
  • Desi I, Dobronyi I, Varga L. Immuno-, neuro-, and general toxicologic animal studies of a synthetic pyrethroid, cypermethrin. Ecotoxicol Environ Saf 1986;12:220–232.
  • Giray B, Gurbay A, Hincal F. Cypermethrin-induced oxidative stress in rat brain and liver is prevented by vitamin E or allopurinol. Toxicol Lett 2001;118:139–146.
  • Kale M, Rathore N, John S, Bhatnagar D. Lipid peroxidation and antioxidant enzymes in rat tissues in pyrethroid toxicity: possible involvement of reactive oxygen species. J Nutr Environ Med 1999;9:37–46.
  • Koller W, Vetere-Overfield B, Gray C, Alexander C, Chin T, Dolezal J, Hassanein R, Tanner C. Environmental risk factors in Parkinson's disease. Neurology 1990;40:1218–1221.
  • Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 1994;36:348–355.
  • Fon EA, Pothos EN, Sun BC, Killeen N, Sulzer D, Edwards RH. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 1997;19: 1271–1283.
  • Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996;379: 606–612.
  • Sora I, Wichems C, Takahashi N, Li XF, Zeng Z, Revay R, Lesch KP, Murphy DL, Uhl GR. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci USA 1998;95:7699–7704.
  • Takahashi N, Miner LL, Sora I, Ujike H, Revay RS, Kostic V, Jackson-Lewis V, Przedborski S, Uhl GR. VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc Natl Acad Sci USA 1997;94:9938–9943.
  • Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Bock CB, Miller GW, Wightman RM, Caron MG. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 1997;19:1285–1296.
  • Liu Y, Peter D, Roghani A, Schuldiner S, Prive GG, Eisenberg D, Brecha N, Edwards RH. A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell 1992;70: 539–551.
  • Xu Z, Cawthon D, McCastlain KA, Slikker W, Jr, Ali SF. Selective alterations of gene expression in mice induced by MPTP. Synapse 2005;55:45–51.
  • Patel S, Singh V, Kumar A, Gupta YK, Singh MP. Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb and paraquat-induced Parkinson's disease phenotype in mouse: mechanism of neurodegeneration. Brain Res 2006;1081:9–18.
  • Mari M, Cederbaum AI. Induction of catalase, alpha, and microsomal glutathione S-transferase in CYP2E1 overexpressing HepG2 cells and protection against short-term oxidative stress. Hepatology 2001;33:652–661.
  • Gupta SP, Patel S, Yadav S, Singh AK, Singh S, Singh MP. Involvement of nitric oxide in maneb- and paraquat-induced Parkinson's disease phenotype in mouse: is there any link with lipid peroxidation? Neurochem Res 2010;35:1206–1213.
  • Kaplowitz N. Biochemical and cellular mechanisms of toxic liver injury. Semin Liver Dis 2002;22:137–144.
  • Lieber CS. CYP2E1: from ASH to NASH. Hepatol Res 2004; 28:1–11.
  • Lieber CS. Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 1997;77:517–544.
  • Habig WH, Pabst MJ, Jacoby WB. Glutathione-S-transferase. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130–7139.
  • Singh AK, Tiwari MN, Upadhyay G, Patel DK, Singh D, Prakash O, Singh MP. Long-term exposure to cypermethrin induces the nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood. Neurobiol Aging 2010; DOI: 10.1016/j.neurobiolaging.2010.02.018.
  • Elwan MA, Richardson JR, Guillot TS, Caudle WM, Miller GW. Pyrethroid pesticide-induced alterations in dopamine transporter function. Toxicol Appl Pharmacol 2006;211:188–197.
  • Gillette JS, Bloomquist JR. Differential up-regulation of striatal dopamine transporter and alpha-synuclein by the pyrethroid insecticide permethrin. Toxicol Appl Pharmacol 2003; 192:287–293.
  • Gonzalez-Hernandez T, Barroso-Chinea P, De La Cruz Muros I, Del Mar Perez-Delgado M, Rodriguez M. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. J Comp Neurol 2004;479:198–215.
  • Garcon G, Gosset P, Zerimech F, Grave-Descampiaux B, Shirali P. Effect of Fe(2)O(3) on the capacity of benzo(a)pyrene to induce polycyclic aromatic hydrocarbon-metabolizing enzymes in the respiratory tract of Sprague-Dawley rats. Toxicol Lett 2004;150:179–189.
  • Thomas T, Jurgen B. Testosterone, cytochrome P450, and cardiac hypertrophy. FASEB J 2002;16:1537–1549.
  • Kumar A, Patel S, Gupta YK, Singh MP. Involvement of endogenous nitric oxide in myeloperoxidase mediated benzo(a)pyrene induced polymorphonuclear leukocytes injury. Mol Cell Biochem 2006;286:43–51.
  • Upadhyay G, Kumar A, Singh, MP. Effect of silymarin on pyrogallol- and rifampicin-induced hepatotoxicity in mouse. Eur J Pharmacol 2007;565:190–201.
  • Koop DR. Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P-450 isozyme 3a. Mol Pharmacol 1986;29:399–404.
  • Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–358.
  • Mun JY, Lee WY, Han SS. Effects of cypermethrin on the dopaminergic neurons in the progressive hemiparkinsonian rats. Toxicol Mech Method 2005;15:399–404.
  • Patel S, Singh K, Singh S, Singh MP. Gene expression profiles of mouse striatum in control and maneb + paraquat-induced Parkinson's disease phenotype: validation of differentially expressed energy metabolizing transcripts. Mol Biotechnol 2008;40:59–68.
  • Miller GW, Gainetdinov RR, Levey AI, Caron MG. Dopamine transporters and neuronal injury. Trends Pharmacol Sci 1999;20:424–429.
  • Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003;39:889–909.
  • Nissbrandt H, Bergquist F, Jonason J, Engberg G. Inhibition of cytochrome P4502E1 induces an increase in extracellular dopamine in rat substantia nigra: a new metabolic pathway? Synapse 2001;40:294–301.
  • Vaglini F, Pardini C, Viaggi C, Bartoli C, Dinucci D, Corsini GU. Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced mouse model of Parkinson's disease. J Neurochem 2004;91:285–298.
  • Hubatsch I, Ridderstrom M, Mannervik B. Human glutathione transferase-A4-4: an alpha class enzyme with high efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation. Biochem J 1998;330: 175–179.
  • Agrawal AK, Shapiro BH. Imprinted over induction of hepatic CYP2B1 and 2B2 in adult rats neonatally exposed to phenobarbital. J Pharmacol Exp Ther 1996;279:991–999.
  • Agrawal AK, Shapiro BH. Latent over expression of hepatic CYP2C7 in adult male and female rats neonatally exposed to Phenobarbital: a developmental profile of gender dependent P450s. J Pharmacol Exp Ther 2000;293:1027–1033.
  • Chinopoulos C, Tretter L, Rozsa A, Adam-Vizi V. Exacerbated responses to oxidative stress by an Na+ load in isolated nerve terminals: the role of ATP depletion and rise of [Ca2+]. J Neurosci 2000;20:2094–2103.
  • Fonne-Pfister R, Bargetzi MJ, Meyer UA. MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450 buf1, P450db1) catalyzing debrisoquine 4-hydroxylation. Biochem Biophys Res Commun 1987;148: 1144–1150.
  • Jimenez-Jimenez FJ, Tabernero C, Mena MA, Garcia de Yebenes J, Garcia de Yebenes MJ, Casarejos MJ, Pardo B, Garcia-Agundez JA, Benitez J, Martinez A. Acute effects of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in a model of rat designated a poor metabolizer of debrisoquine. J Neurochem 1991;57:81–87.
  • Nasuti C, Gabbianelli R, Falcioni ML, Di Stefano A, Sozio P, Cantalamessa F. Dopaminergic system modulation, behavioral changes and oxidative stress after neonatal administration of pyrethroids. Toxicology 2007;229:194–205.
  • Dobbing J. Prenatal nutrition and neurological development. UCLA Forum Med Sci 1975;18:401–420.
  • Lajtha A, Dunlop D. Turnover of protein in the nervous system. Life Sci 1981;29:755–767.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.